期刊文献+

麻疹、腮腺炎、风疹三联减毒活疫苗的安全性和免疫原性研究 被引量:13

Evaluation on the safety and immunogenicity of a new measles-mumps-rubella vaccine(MMR) with a licensed vaccines
下载PDF
导出
摘要 为了评价国产麻疹、腮腺炎、风疹三联减毒活疫苗(MMR)的安全性和免疫原性,按整体随机抽样原则,以进口同类疫苗和国产各单价疫苗作为对照,开展现场临床观察;比较不同疫苗组免疫后的反应率、抗体阳转率、保护率及几何平均滴度(GMT)。试验组与对照组接种后,除了试验疫苗的中、强发热反应率高于进口对照疫苗的发热反应率(8.60%与2.00%)外,未见其它有显著差异的不良反应。试验组麻疹免后抗体阳转率高于进口对照疫苗(99.5%与94.6%),麻疹抗体GMT也高于单价麻疹对照疫苗的GMT;试验疫苗与进口MMR疫苗的风疹抗体阳转率、腮腺炎抗体阳转率相比,均无显著性差异。实验研究结果显示,试验MMR疫苗与进口MMR疫苗具有相似的临床反应及良好的免疫原性。 To evaluate the safety and immunogenicity of a new measles-mumps-rubella ( Hu MMR ) vaccine in comparison with licensed MMR (Merck), monovalent measles vaccine, monovalent mumps vaccine and monovalent rubella vaccine. 1188 healthy children between 8 and 18 months were enrolled. They were randomized into four groups to receive different vaccines. Except candidate vaccine group had higher fever rates than that of Merck group(8.60% and 2.00% ,respectively ), the incidences of all other solicited local and general symptoms were comparable between the two groups. Seroconversion rate of measles antibody in trial group was higher than that of Merck MMR vaccine group(99.5% vs 94.6% ). GMT of measles antibody in trial group was also higher than that of measles vaccine group. Seroconversion rates of mumps and rubella antibodies had no significant difference between trial group and Merck vaccine group. In conclusion, the new MMR vaccine demonstrated satisfactory immunogenicity and safety profiles as good as the Merck MMR vaccine.
出处 《微生物学免疫学进展》 2008年第2期1-4,共4页 Progress In Microbiology and Immunology
关键词 麻疹 腮腺炎 风疹三联减毒活疫苗 安全性 免疫原性 Measles-mumps-rubella ( MMR ) vaccine Safety Immunogenicity
  • 相关文献

参考文献8

  • 1韩雅儒.麻疹、腮腺炎、风疹三联活疫苗[M].见张延龄,张晖主编.疫苗学.第1版.北京:科学出版社,2004.1291-1303.
  • 2郭可謇..麻疹、风疹[M]..黄祯祥,洪涛,刘崇柏主编..医学病毒学基础及实验技术.第1版..北京:科学出版社,,1990..753-781..
  • 3Peltola H,Heinoeu OP,Valle M,et al.The elimination of indigenous measles,mumps and rubella from Finland by a 12-year,two-dose vaccine program[J].N Engl.Med 1994,331:1398-1402.
  • 4施燕,胡家瑜,汤素文,吴维寿,许文忠.上海市麻疹、流行性腮腺炎、风疹抗体水平调查分析[J].上海预防医学,2004,16(8):378-379. 被引量:39
  • 5郭绍红,徐天强,吴维寿,董春明,王刚毅,许琪,施燕,陈海平,迮文远.冻干流行性腮腺炎减毒活疫苗人体反应及免疫效果观察[J].中国计划免疫,1997,3(1):1-4. 被引量:23
  • 6王树声 韩亚儒 董春明 等.BRD-Ⅱ株和RA27/3株风疹减毒活疫苗临床反应和免疫原性的研究[J].中华微生物学和免疫学杂志,1984,4:250-252.
  • 7许文波,朱贞,张珍英,王同展,蒋小泓,王常银,何维宽,王建国,李聪勇,郑蕾,凌华,李平,刘桂艳,田宏,周淑洁,田疆,王步安.麻疹野病毒H1基因型在中国流行的分析[J].中国计划免疫,2003,9(1):1-8. 被引量:145
  • 8赵锦铭..流行性腮腺炎[M]..黄祯祥,洪涛,刘崇柏主编..医学病毒学基础及实验技术.第1版..北京:科学出版社,,1990..753-781..

二级参考文献10

共引文献203

同被引文献97

引证文献13

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部